Skip to main content
Watch Insiders
ORICHealthcare

ORIC Pharmaceuticals Inc (ORIC) Insider Trading

In the last 90 days, 2 ORIC Pharmaceuticals Inc (ORIC) insiders reported no open-market purchases and 5 sales totaling $1,519,090. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 20, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 20, 2026Dominic PiscitelliChief Financial OfficerSale14,000$13.53$189,391
Oct 1, 2026Richard A. HeymanDirectorSale6,700$12.91$86,524
Sep 28, 2026Dominic PiscitelliChief Financial OfficerSale13,400$13.53$181,258
Sep 24, 2026Dominic PiscitelliChief Financial OfficerSale600$13.50$8,103
Aug 26, 2026Dominic PiscitelliChief Financial OfficerSale77,000$13.69$1,053,814
Jul 24, 2026Richard A. HeymanDirectorSale13,100$12.02$157,462
Jul 6, 2026Richard A. HeymanDirectorSale300$12.00$3,600

Common questions

ORIC insider trading FAQ

Are ORIC insiders buying or selling?
Over the last 90 days, ORIC insiders were net sellers, reporting $0.00 of open-market purchases and $1,519,090 of sales.
When was the last ORIC insider purchase?
No open-market insider purchase of ORIC Pharmaceuticals Inc stock was reported in the last 90 days.
Where does ORIC insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that ORIC Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.